Home > National Drug Code (NDC) > Methotrexate

Methotrexate - 67457-221-02 - (Methotrexate)

Alphabetical Index


Drug Information of Methotrexate

Product NDC: 67457-221
Proprietary Name: Methotrexate
Non Proprietary Name: Methotrexate
Active Ingredient(s): 1    g/40mL & nbsp;   Methotrexate
Administration Route(s): INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Methotrexate

Product NDC: 67457-221
Labeler Name: Mylan Institutional LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA040716
Marketing Category: ANDA
Start Marketing Date: 20120627

Package Information of Methotrexate

Package NDC: 67457-221-02
Package Description: 1 VIAL, GLASS in 1 CARTON (67457-221-02) > 2 mL in 1 VIAL, GLASS

NDC Information of Methotrexate

NDC Code 67457-221-02
Proprietary Name Methotrexate
Package Description 1 VIAL, GLASS in 1 CARTON (67457-221-02) > 2 mL in 1 VIAL, GLASS
Product NDC 67457-221
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Methotrexate
Dosage Form Name INJECTION, SOLUTION
Route Name INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS
Start Marketing Date 20120627
Marketing Category Name ANDA
Labeler Name Mylan Institutional LLC
Substance Name METHOTREXATE
Strength Number 1
Strength Unit g/40mL
Pharmaceutical Classes Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]

Complete Information of Methotrexate


General Information